bioAffinity Technologies Announces Award of Canadian Patent

PUBLISHED ON February 5, 2019

SAN ANTONIO, TX (February 4, 2019) bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the Company’s claims associated with its proprietary CyPath© technology for the early detection of cancer.